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Expression of Bmi-1 in Epidermis Enhances Cell
Survival by Altering Cell Cycle Regulatory Protein
Expression and Inhibiting Apoptosis
Kathy Lee1, Gautam Adhikary1, Sivaprakasam Balasubramanian1, Ramamurthy Gopalakrishnan1,
Thomas McCormick2, Goberdhan P. Dimri3, Richard L. Eckert1,2,4,5 and Ellen A. Rorke6
The polycomb group (PcG) genes are epigenetic suppressors of gene expression that play an important role in
development. In this study, we examine the role of Bmi-1 (B-cell-specific Moloney murine leukemia virus
integration site 1) as a regulator of human epidermal keratinocyte survival. We identify Bmi-1 mRNA and protein
expression in epidermis and in cultured human keratinocytes. Bmi-1 is located in the nucleus in cultured
keratinocytes, and in epidermis it is expressed in the basal and suprabasal layers. Adenovirus-delivered Bmi-1
promotes keratinocyte survival and protects keratinocytes from stress agent-mediated cell death. This is
associated with increased levels of cyclin D1 and selected cyclin-dependent kinases, and reduced caspase
activity and poly(ADP-ribose) polymerase (PARP) cleavage. Bmi-1 may be involved in the maintenance of disease
state, as Bmi-1 levels are elevated in transformed keratinocytes, skin tumors, and psoriasis. The presence of Bmi-1
in suprabasal non-proliferative cells of the epidermis and within a high percentage of cells within skin tumors
suggests a non-stem cell pro-survival role for Bmi-1 in this tissue. Based on the suprabasal distribution of Bmi-1
in epidermis, we propose that Bmi-1 may promote maintenance of suprabasal keratinocyte survival to prevent
premature death during differentiation. Such a function would help assure proper formation of the stratified
epidermis.
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INTRODUCTION
The polycomb group (PcG) genes play a centrally important
role in mammalian development. Bmi-1 (B-cell-specific
Moloney murine leukemia virus integration site 1) is the
mammalian form of a Drosophila PcG protein that regulates
stem cell maintenance and renewal (Lessard et al., 1999;
Ohta et al., 2002; Park et al., 2003). Bmi-1 is an epigenetic
regulator that is thought to act, in some systems, by
suppressing ink4a/ARF locus gene expression. This locus
encodes the cell cycle progression suppressor proteins
p16ink4a and p19arf (p14arf in humans). Bmi-1-dependent
suppression of p16ink4a and 19arf level, and the level of other
cell cycle suppressor proteins, leads to enhanced stem cell
survival and proliferation (Iwama et al., 2004). Disruption of
Bmi-1 action has profound effects on development (Iwama
et al., 2004). For example, Bmi-1/ mice are unable to
efficiently renew hematopoietic stem cells, a response that
has been attributed to the absence of normal, tonic Bmi-1-
dependent suppression of p16Ink4a and p19Arf levels (Jacobs
et al., 1999a; Molofsky et al., 2003; Park et al., 2003).
Reduced stem cell renewal is also observed for leukemic and
neuronal stem cells in Bmi-1/ mice (Lessard and Sauva-
geau, 2003; Molofsky et al., 2003). In addition to these effects
on stem cells, it has been suggested that Bmi-1 may enhance
tumor cell proliferation/survival by repressing transcription
of p16ink4 and p19arf (Kim et al., 2004) and via Bmi-1-
dependent increased expression and activity of telomerase
reverse transcriptase (Dimri et al., 2002). Telomerase reverse
transcriptase is the catalytic protein subunit of telomerase,
which is responsible for maintenance of telomere length,
and telomerase reverse transcriptase activation is associated
with cell immortalization (Dimri et al., 2002). Taken
together, these findings suggest an important role for Bmi-1
in regulating normal cell physiology and as a pro-survival/
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proliferation factor in hyperproliferative diseases and
epithelial cancer (Vonlanthen et al., 2001; Dimri et al., 2002;
Kim et al., 2004).
The epidermis is a stratifying multilayered epithelium in
which proliferating cells, located in the basal layer, undergo
regulated cell division (Fuchs and Byrne, 1994). This cell
division results in the production of daughter cells that move
into the suprabasal epidermal layers and undergo differentia-
tion (Eckert et al., 1997). These differentiating cells lose the
ability to proliferate, but they remain viable until the final
stage of the differentiation process. Understanding the
process whereby these cells cease proliferation and are
maintained during the differentiation program is a major goal.
In this study, we explore the role of Bmi-1 as a regulator of
keratinocyte function. We show that Bmi-1 is expressed in
cultured epidermal keratinocytes and in human epidermis,
and that overexpression of Bmi-1 in cultured normal human
keratinocytes promotes increased cell numbers. In addition,
Bmi-1 protects keratinocytes from challenge with stress
agents (UVB, okadaic acid (OA), etc.), and Bmi-1 levels are
elevated in psoriasis and in squamous cell cancer, suggesting
a role in promoting tumor cell survival. These effects are
associated with changes in cell cycle regulatory protein
expression and suppression of keratinocyte apoptosis. Based
on these findings, we propose that Bmi-1 plays an important
role in maintaining proliferation of basal keratinocytes and in
viability of differentiating suprabasal keratinocytes. These
findings suggest that Bmi-1, which was originally identified as
a stem cell maintenance factor, may have a non-stem cell
role in epidermis in maintaining the survival of differentiating
suprabasal keratinocytes.
RESULTS
Bmi-1 is expressed in keratinocytes
A major goal of this study was to assess whether Bmi-1 has
a role in regulating normal human epidermal keratinocyte
survival. Bmi-1 has been reported to be expressed in
epidermal keratinocytes maintained on 3T3 feeder cells and
also in cultured hair follicle-derived stem cells (Claudinot
et al., 2005; Maurelli et al., 2006). We first confirmed that
Bmi-1 is expressed in cultured epidermal keratinocytes when
maintained in keratinocyte serum-free medium and cultured
on plastic. As shown in Figure 1a, Bmi-1-encoding mRNA, as
assessed by reverse transcription-PCR (RT-PCR) analysis, is
expressed. Moreover, as shown in Figure 1b, in which total
keratinocyte extracts were incubated in the presence (þ )
or absence () of anti-Bmi-1, Bmi-1 protein is also present.
As PcG gene products, including Bmi-1, act in the nucleus
(Cohen et al., 1996), we monitored the subcellular localiza-
tion of Bmi-1. Keratinocytes, grown on glass coverslips, were
immunostained with anti-Bmi-1. As shown in Figure 1c,
endogenous hBmi-1 is detected in the nucleus.
To confirm Bmi-1 expression in human epidermis, kerati-
nocyte RNA was isolated and Bmi-1 mRNA was detected
by RT-PCR. As shown in Figure 2a, Bmi-1-encoding mRNA
is detected in foreskin epidermis. Moreover, incubation
of foreskin epidermal extracts with anti-Bmi-1 reveals the
presence of Bmi-1 protein (Figure 2b). We then examined
foreskin sections using immunohistological analysis to monitor
Bmi-1 tissue distribution. As shown in Figure 2c, although
Bmi-1 is detected in some of the basal layer proliferative cells,
immunoreactivity is also detected, in a dispersed distribution,
in the suprabasal epidermal layers. Little or no Bmi-1
expression is detected in the dermis. The presence of
suprabasal Bmi-1 is consistent with a recent report (Reinisch
et al., 2007). The fact that Bmi-1 is expressed at high levels
throughout the suprabasal layers is interesting as it indicates
that Bmi-1 may have a non-stem cell role in this tissue.
Bmi-1 expression promotes keratinocyte proliferation
The above studies demonstrate that Bmi-1 is present in the
nucleus of cultured keratinocytes and is also expressed in
epidermis. To assess its functional role, Bmi-1 was over-
expressed using an adenoviral vector. As shown in Figure 3a,
infection of primary keratinocytes with tAd5-hBmi-1 results
in a fivefold increase in intracellular Bmi-1 level. To assess
the impact on cell number, keratinocytes were infected with
tAd5-EV or tAd5-hBmi-1 and cell number was monitored
after 72 hours. In tAd5-EV-infected cells, keratinocyte cell
number increased threefold at 72 hours post infection owing
to normal cell growth over the 3-day period. In contrast, cell
number increased sevenfold in Bmi-1-expressing cultures
(Figure 3b). To assess whether this increase in cell number is
reflected at the level of DNA synthesis, we monitored
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Figure 1. Bmi-1 is expressed in the nucleus of cultured normal human
keratinocytes. (a) Total RNA (500 ng), prepared from near-confluent cultures
of normal human epidermal keratinocytes, was amplified by RT-PCR in the
presence or absence of 400 nM of the appropriate primers, and the resulting
cDNA product was detected by ethidium bromide staining (arrow).
M indicates the migration of DNA size markers (nucleotides). b-Actin RNA
was amplified to a similar level in each sample (not shown). (b) Total cell
extract, prepared from near-confluent cultures of normal human
keratinocytes, was electrophoresed on an 8% polyacrylamide gel for
immunoblot. Parallel lanes were incubated in the presence (þ ) or absence
() of mouse monoclonal anti-Bmi-1 (diluted 1:500) followed by addition of
the secondary antibody and visualization using enhanced chemiluminescent
reagent. b-Actin levels were measured to normalize protein loading. (c)
Keratinocytes, growing on glass coverslips, were fixed and incubated in the
presence or absence of mouse monoclonal anti-Bmi-1 (diluted 1:25) followed
by incubation with Cy3-conjugated sheep anti-mouse IgG (1:1,000). The
arrows indicate nuclear Bmi-1. Similar results were observed in each of the
three separate experiments.
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[3H]thymidine incorporation into the DNA of cells treated as
above. As shown in Figure 3c, the increase in cell number is
associated with a parallel increase in DNA synthesis,
indicating that more cells are progressing through S phase
in the Bmi-1-expressing cells.
Bmi-1 protects keratinocytes from challenge with stress agents
We next monitored the impact of Bmi-1 on keratinocyte
survival following stress agent challenge. Keratinocytes were
infected with tAd5-EV or tAd5-hBmi-1, and, after 24 hours,
treated with 12-O-tetradecanoylphorbol-13-acetate (TPA) or
OA. At 48 hours post infection, the cells were examined. Our
previous studies show that treatment with TPA or OA reduces
keratinocyte survival (Welter et al., 1995; Efimova et al.,
2003). As shown in Figure 4a, expression of Bmi-1 produces a
marked increase in the survival of TPA-treated keratinocytes.
Figure 4b shows the impact of Bmi-1 on the response to
treatment with OA. Figure 4c provides a quantitative
assessment of the change in cell number for the treatments
shown in Figure 4a and b. This experiment shows that
the reduction in cell survival observed in cells treated with
2 or 10 nM can be reversed by Bmi-1; however, the Bmi-1-
dependent protection is less when the cells are challenged
with the higher (10 nM) OA concentration. This suggests, as
could reasonably be expected, that the ability of Bmi-1 to
protect cells is limited and that high concentrations of stress
agent may overwhelm the protective effects of Bmi-1.
Bmi-1-dependent alteration in cell cycle regulatory protein
expression
Previous studies in other systems suggest that Bmi-1 may
enhance cell survival by regulating the level of cell cycle
regulatory proteins (Jacobs et al., 1999a; Molofsky et al.,
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Figure 2. Bmi-1 is expressed in human epidermis. (a) Total RNA (500 ng),
prepared from dispase-separated human foreskin epidermis, was amplified by
RT-PCR in the presence or absence of 400 nM of each primer, and the resulting
DNA product was detected by ethidium bromide staining (in vivo) (arrow).
The sample indicated ‘‘K’’ is the RT-PCR product detected using RNA isolated
from tAd5-hBmi-1-infected cultured human keratinocytes. M indicates the
migration of DNA size markers (nucleotides). (b) Total cell extract was
prepared from dispase-separated human foreskin epidermis (in vivo) or from
cultured normal human keratinocytes (K) and electrophoresed on an 8%
polyacrylamide before immunoblot using anti-Bmi-1 (1:500) and HRP-
conjugated sheep anti-mouse IgG secondary antibody (1:5,000). Secondary
antibody binding was visualized using enhanced chemiluminescent reagent.
b-actin levels were measured to normalize protein loading. (c) Human
epidermal tissue sections were paraffin embedded, deparaffinized, and
hydrated through xylene and a graded alcohol series. Following incubation in
0.3% H2O2 for 30 minutes, the tissue sections were washed with PBS for
5 minutes and blocked for 1 hour in PBS containing 1% normal goat serum
and 1 mg/ml bovine serum albumin. The primary antibody (mouse
monoclonal anti-Bmi-1, diluted 1:50) was added for 2 hours at room
temperature followed by incubation for 30 minutes with the secondary
antibody (biotinylated horse anti-mouse, 1:1,000) and the signal was
visualized using the Vectastain kit (Vector Laboratories, Burlingame, CA). The
sections were washed and then counterstained with hematoxylin (Fisher,
Pittsburgh, PA) and sealed under coverslips. The top panel (control) was
incubated with secondary antibody and the bottom panel (anti-Bmi-1) was
incubated with both primary and secondary antibodies. The arrows indicate
the epidermal basal layer. Bar¼50 mm. This experiment was repeated three
times with similar results in each experiment.
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Figure 3. Bmi-1 expression increases keratinocyte cell number. (a) Thirty
percent confluent 50 cm2 dishes of normal human keratinocytes were infected
with 5 MOI of tAd5-hBmi-1 or tAd5-EV in the presence of 5 MOI Ad5-TA
virus. After 24 hours, fresh virus-free medium was added for an additional
24 hours. At 48 hours post infection, the cells were harvested and extracts
were prepared for electrophoresis and immunoblot with anti-Bmi-1. b-actin
was detected in parallel as a protein normalization control. (b) Keratinocytes
were treated with virus as indicated above, and at 48 hours post infection they
were harvested and counted. The open bar (control) is the cell number on day
zero at the time of initiation of virus treatment and the shaded bars are the cell
counts at 72 hours post infection. Note that the cells grow at a normal rate in
the presence of tAd5-EV, such that cell number has increased several fold by
72 hours. As assessed by the Student’s t-text, the difference between the
means of the tAd5-EV and tAd5-hBmi-1 groups is significant at the 95%
confidence interval. (c) Keratinocytes were treated with virus as above, and
during the final 2 hours of the 48 hours growth period they were pulsed with
1mCi/ml [3H]thymidine. The cells were then washed twice with ice-cold PBS,
twice with ice-cold 5% (w/v) trichloroacetic acid, and then dissolved in 0.2 M
NaOH. Incorporated [3H]thymidine was measured by liquid scintillation
counting. Identical results were observed in each of the three experiments.
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2003; Park et al., 2003; Kim et al., 2004). We therefore
determined whether Bmi-1 produces this response. As shown
in Figure 5a, hBmi-1 expression does not alter the expression
of the cyclin-dependent kinase inhibitor, p21. In addition,
p16Ink4a level, which is known to be reduced by Bmi-1 in
other systems (Jacobs et al., 1999a; Molofsky et al., 2003;
Park et al., 2003), is not regulated by Bmi-1 in keratinocytes
grown under the present conditions (Figure 5a). The absence
of modulation of Bmi-1 level is consistent with a recent report
in SCC-4 oral cancer cells, where cell growth was slowed
by siRNA knockdown of Bmi-1 expression, but this was
not associated with reduced p16Ink4a level (Kang et al., 2007).
In contrast, Bmi-1 expression does increase expression of the
cyclin-dependent kinases cdk2 and cdk4, and the level of
cyclin D1. These findings suggest that Bmi-1 can influence
cell cycle progression via regulation of a host of cell cycle
regulators.
A second mechanism whereby Bmi-1 may enhance cell
survival is by inhibition of apoptosis. In keratinocytes,
apoptosis involves the loss of mitochondrial membrane
potential with accompanying release of apoptogenic factors,
including cytochrome c, and activation of cysteine-depen-
dent aspartate-directed proteases known as caspases (Den-
ning et al., 2002; Waterhouse et al., 2002; Scorrano and
Korsmeyer, 2003). Poly(ADP-ribose) polymerase (PARP), a
DNA nick-sensing protein that is involved in DNA repair and
is a downstream target of caspase-3, is also cleaved (Scorrano
and Korsmeyer, 2003). To assess whether Bmi-1 influences
apoptosis, we monitored the extent of pro-caspase and PARP
cleavage in cells expressing Bmi-1. Keratinocytes were
treated with tAd5-EV or tAd5-hBmi-1 for 24 hours, followed
by treatment with OA in virus-free medium for an additional
24 or 48 hours. At 24 and 48 hours post infection, the cells
were harvested and assayed for pro-caspase 3 and PARP
cleavage (Figure 5b). Cleavage of these proteins is associated
with their activation (Adams and Cory, 2002; Shi, 2002). OA
treatment of EV-infected cells produces a marked increase in
pro-caspase 3 and PARP cleavage products at 24 and
48 hours. In contrast, the presence of Bmi-1 inhibits produc-
tion of these cleavage products. Ultraviolet light exposure is a
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Figure 4. Bmi-1-expressing keratinocytes are resistant to stress-induced cell death. (a) Twenty percent confluent cultures of normal human keratinocytes
were infected with 5 MOI of tAd5-EV (EV) or tAd5-hBmi-1 (Bmi-1) in the presence of 5 MOI of Ad5-TA. At 24 hours post infection, fresh virus-free medium,
containing the indicated concentration of TPA, was added and incubation was continued for an additional 24 hours before the cells were photographed.
(b) Twenty percent confluent keratinocyte cultures were treated for 24 hours with virus as outlined above followed by an additional 24 hours in virus-free
medium containing 2 or 10 nM OA. The cells were then photographed. (c) Graphical analysis of the change in cell number in the absence or presence of
Bmi-1 and challenge with TPA or OA. The experiment shown in panels a and b was repeated three times and the data were plotted. As assessed by the Student’s
t-text, the difference between the means of the tAd5-EV and tAd5-hBmi-1 groups is significant for each treatment (50 ng/ml TPA, 2 nM OA, and 10 nM OA)
at the 95% confidence interval.
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particularly important apoptotic stimulus in epidermis that
results in the production of apoptotic ‘‘sunburned’’ cells
(Bayerl et al., 1995). To assess the impact of Bmi-1 expression
on the cellular response to this physiologic apoptotic
stimulus, cells were infected with tAd-EV or tAd-hBmi-1
for 24 hours, exposed to 50 mJ/cm2 UVB, and then harvested
at 48 hours post infection for preparation of cell extracts.
As shown in Figure 5b, Bmi-1 expression results in a sub-
stantial reduction in UVB-dependent pro-caspase 3 and
PARP cleavage. These findings suggest that Bmi-1 inhibits
apoptosis.
Bmi-1 expression in skin tumors and in involved psoriatic tissue
As Bmi-1 expression has been reported to immortalize cells
(Dimri et al., 2002), and Bmi-1 overexpression has been
reported in tumors (Vonlanthen et al., 2001; Kim et al., 2004),
we hypothesized that increased Bmi-1 expression may
be associated with hyperproliferative epidermal diseases,
including psoriasis and cancer. We first examined its
expression in transformed keratinocyte-derived cell lines. As
shown in Figure 6a, Bmi-1 mRNA is readily detected in A431,
HaCaT, and SCC-13 cells. Moreover, the level of expression
is markedly increased compared to that observed in normal
foreskin keratinocytes (KERN). To assess the expression
pattern in squamous cell carcinoma, we stained tumor
sections with anti-Bmi-1. As shown in Figure 6b, Bmi-1 is
present in invasive squamous cell carcinoma. Staining is
evident throughout the tumor, with less staining apparent at
the tumor margins (þ anti-Bmi-1). No staining is observed
when the primary antibody is omitted (anti-Bmi-1).
To assess whether Bmi-1 is expressed in other epidermal
hyperproliferative diseases, we measured Bmi-1 expression in
psoriasis. As shown in Figure 7a, incubation with anti-Bmi-1
reveals substantial staining in psoriatic tissue (þ anti-Bmi-1).
This staining is not observed in sections incubated in
the absence of primary antibody ( anti-Bmi-1). To study
the association between increased Bmi-1 level and increased
proliferation, we transplanted human involved psoriatic
tissue onto severe combined immunodeficiency (SCID) mice
and monitored the level and distribution of Bmi-1 before and
after treatment with the immunosuppressive agent, cyclos-
porine (Nickoloff, 1999, 2000). Cyclosporine treatment
normalizes involved psoriatic tissue implanted onto SCID
mice (Dam et al., 1999). As shown in Figure 7b, the involved
psoriatic tissue displays the characteristic epithelial expan-
sion into the underlying dermis (left panel). Moreover, Bmi-1
staining reveals the presence of focal Bmi-1 expression
(arrows). In addition, treatment with cyclosporine norma-
lizes the tissue morphology and reduces Bmi-1 expression.
Although Bmi-1 is present at scattered locations in the
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Figure 5. Bmi-1 enhances keratinocyte cell survival. (a) Keratinocytes were
infected with 5 MOI of tAd5-EV or tAd5-hBmi-1 in the presence of 5 MOI of
Ad5-TA. After 24 hours, fresh virus-free medium was added and the cells were
incubated for an additional 24 hours. Total extract was then prepared and
electrophoresed for immunoblot to detect the presence of the indicated
proteins. The b-actin immunoblot was included to assure equivalent protein
loading. (b) Keratinocytes were infected with 5 MOI of tAd5-EV or tAd5-hBmi-1
for 24 hours. Fresh virus-free medium was then added and the cells were
incubated with 2 nM OA for an additional 24 or 48 hours. Total extract was
then prepared and electrophoresed for immunoblot with anti-PARP or anti-
pro-caspase 3. A b-actin immunoblot was included to assure equivalent
protein loading. (c) Keratinocytes were infected with adenovirus as outlined
above, and after 24 hours they were treated with 50 mJ/cm2 UVB. After an
additional 48 hours, the cells were harvested and assayed for PARP and
pro-caspase 3 cleavage products by immunoblot. The arrows indicate the
intact forms of PARP and pro-caspase 3. The asterisks indicate migration of
cleaved forms. This experiment was repeated four times with similar results
in each repeat.
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Figure 6. Bmi-1 is expressed in squamous cell tumors and expression is
increased in cancer cell lines. (a) Bmi-1 is overexpressed in tumor cell lines.
Total protein extracts were prepared from near-confluent cultures of A431,
HaCaT, SCC13 cells, and normal human keratinocytes, and electrophoresed.
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Bar¼50 mm. Bmi-1 is detected in all areas, but not along the margins where
the tumor meets the connective tissue.
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normalized tissue, the levels are reduced compared to that
observed in involved psoriatic tissue. An interesting feature is
that the highest level of staining is observed in the suprabasal
layers in the tissue, a pattern that is similar to that observed in
normal epidermis (see Figure 2c).
DISCUSSION
The PcG genes encode a family of evolutionarily conserved
regulators that were discovered in Drosophila as repressors
of Homoeotic genes, which are involved in establishing
body segmentation patterns during development. In mamma-
lian systems, PcG proteins regulate genes involved in
development and differentiation via epigenetic mechanisms
(e.g., chromatin modification). PcG genes are important
regulators of organogenesis and development, as the repro-
gramming of stem cells requires epigenetic alterations (e.g.,
methylation) to specify and maintain long-term changes in
gene expression. Proteins encoded by PcG genes comprise
two distinct protein complexes that act coordinately to
regulate gene expression – the ‘‘Bmi-1 complex’’ and the
‘‘Eed complex’’. The Eed complex includes Eed, EzH1, and
EzH2. The Bmi-1 complex includes Bmi-1, Mel-18, Mph1/
Rae28, M33, Scmh1, and Ring1A/B. The Eed-containing
complex controls gene repression through recruitment of
histone deacetylase. This recruitment leads to local chroma-
tin deacetylation and subsequent methylation of Lys27 of
histone H3. The Bmi-1 complex subsequently binds to
methylated Lys27 of histone H3, created by Eed complex
action, to suppress gene expression and contribute to the
maintenance of epigenetic memory (Fischle et al., 2003).
Thus, these complexes act coordinately to maintain changes
in gene expression during development (Jacobs and van,
2002; Orlando, 2003).
Bmi-1 is expressed in keratinocytes
Because the epidermis is a renewing tissue and the survival of
differentiating keratinocytes must be controlled to produce a
normal epidermal barrier, we assessed whether Bmi-1 is
present and if it has a regulatory role in keratinocytes. Bmi-1
is localized in the nucleus of cultured normal human
epidermal keratinocytes, consistent with a previous report
indicating a nuclear localization in fibroblasts (Cohen et al.,
1996). This localization appears to be necessary for function,
as Bmi-1 mutants that cannot localize in the nucleus are
inactive (Cohen et al., 1996).
Several studies suggest that the pro-survival, pro-prolifera-
tion action of Bmi-1 may be due to its ability to suppress
expression of proteins that regulate cell cycle progression. For
example, in some cell types, in the absence of Bmi-1, the
levels of p16ink4a and p19arf increase (Jacobs et al., 1999a, b).
p16ink4a and p19arf are products of the ink4a-arf locus that
function to suppress cell cycle progression. p16ink4a inhibits
cell cycle progression by inhibiting cyclin D-dependent
kinases, and thereby prevents phosphorylation of Rb
(Serrano et al., 1993). p19arf (p14arf in humans) prevents the
degradation and inactivation of the p53 tumor suppressor
protein by binding to MDM2 (Serrano et al., 1993; Weber
et al., 1999). It is interesting that p16Ink4a is expressed at low
levels in keratinocytes cultured under the present conditions
and that no change in the level of p16INK4a is observed in
response to Bmi-1 overexpression. This finding is consistent
with recent studies showing that Bmi-1 expression does not
alter p16Ink4a expression in oral epithelial cells (Kang et al.,
2007). Nor did we observe a change in p21 level. However,
changes were observed with other cell cycle regulatory
proteins including increased cyclin D1, and cdk2 and cdk4
levels. This is consistent with a recent report suggesting that
many Bmi-1 targets may exist (Bracken et al., 2006). Thus,
our study suggests that Bmi-1 regulates several molecular
targets that control progression through the G1 phase of the
cell cycle.
Bmi-1 in adult tissues and malignancy
Bmi-1 function is required for maintenance of adult stem
cells. Aging Bmi-1/ mice progressively lose stem cells in
the leukemic, neuronal, and cerebellar granule cell lineages
(Jacobs et al., 1999a; Lessard and Sauvageau, 2003; Molofsky
et al., 2003; Park et al., 2003; Leung et al., 2004), and Bmi-1-
deficient fibroblasts express elevated levels of p16ink4a and
p19arf and proliferate slowly (Jacobs et al., 1999b). In
addition, Bmi-1 overexpression enhances cell proliferation
(Lessard and Sauvageau, 2003), Bmi-1 can cooperate with
myc in lymphomagenesis (Haupt et al., 1991), and Bmi-1 is
overexpressed in human colorectal cancer (Kim et al., 2004)
and human non-small cell lung cancer (NSCLC) (Vonlanthen
et al., 2001). These findings suggest that Bmi-1 has a role in
regulating both stem cell and adult somatic cell proliferation
and survival. Our findings are consistent with a role for Bmi-1
in enhancing the survival of mature keratinocytes. We also
show that Bmi-1 is expressed in squamous cell carcinoma
and is present in active psoriatic lesions, and is overexpressed
in cultured skin cancer cells. Moreover, in a model in which
–
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Figure 7. Bmi-1 is expressed in human psoriatic tissue and expression is
reduced following tissue normalization. (a) Bmi-1 expression is elevated in
psoriasis. Punch biopsies were derived from involved psoriatic tissue and
incubated with secondary antibody alone (anti-Bmi-1) or in the presence of
both primary and secondary antibody (þ anti-Bmi-1). Bars¼50 mm. The
arrows indicate Bmi-1 staining. (b) Normalization of psoriatic phenotype is
associated with reduced Bmi-1 expression. Human involved psoriatic tissue
was transplanted onto SCID mice. Parallel grafts were treated with or without
cyclosporine A for 3 weeks. The tissue was then harvested, fixed, and stained
with anti-Bmi-1. Bars¼ 50mm. The arrows indicate Bmi-1 staining. The extent
of the epidermis is indicated in parentheses (Epi).
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human psoriatic tissue is engrafted onto the SCID mouse,
Bmi-1 expression is observed in the active psoriatic tissue,
but is reduced or absent when the tissue is normalized by
treatment of the mice with cyclosporine. These findings
suggest that Bmi-1 may play a role in the development
and maintenance of hyperproliferative skin diseases, and is
consistent with the observation that Bmi-1 is overexpressed in
other tumor types (Vonlanthen et al., 2001; Dimri et al.,
2002; Kim et al., 2004).
Bmi-1 expression in epidermis –a non-stem cell survival role for
Bmi-1
Based on its reported role in regulating stem cell survival, we
had anticipated that Bmi-1 may be specifically expressed in a
limited number of cells in the proliferating compartments of
the epidermis – in the epidermal basal layer or in the hair
follicle bulge (Alonso and Fuchs, 2003; Lavker et al., 2003;
Claudinot et al., 2005; Maurelli et al., 2006). Thus, we were
surprised that although Bmi-1 is expressed in basal cells,
staining is also observed in a scattered pattern in the
suprabasal layers. This finding is consistent with the recent
report of Reinisch et al. (2007). This is particularly interesting,
as cells of the suprabasal layers (spinous and granular),
although metabolically active and viable, have limited proli-
ferative potential. These cells are undergoing differentiation,
which is associated with the expression of a host of terminal
differentiation products including involucrin, loricrin, filag-
grin, etc. (Eckert et al., 1997). Ultimately, these cells survive
until they reach the transition zone in the upper epidermis,
where they undergo terminal differentiation and cornification
(Eckert et al., 1997). This process ultimately leads to the
enzymatic destruction of all intracellular structures, the
assembly of keratin bundles, and the assembly of the
cornified envelope (Green, 1980; Eckert et al., 1997). Based
on the pattern of Bmi-1 expression in epidermis, we propose
that one role of Bmi-1 is to assist in the maintenance of non-
proliferative suprabasal keratinocytes to prevent premature
death.
Bmi-1 and keratinocyte apoptosis
Our results also suggest that Bmi-1 may modulate the
response of the epidermis to stress. Bmi-1 expression
maintains survival of cells following challenge with stress
agents, including OA, TPA, and UVB. UVB exposure is
known to induce caspase-associated keratinocyte cell death,
which ultimately results in the formation of sunburn cells –
the products of light-induced apoptosis (Conney et al., 1992;
Bayerl et al., 1995). These cells express activated killer and
executioner caspases (Shimizu et al., 1999; Lu et al., 2002).
Our studies show that Bmi-1 expression can reverse or slow
this process. Only one report has addressed a possible role for
Bmi-1 in regulating apoptosis. In this study, it was suggested
that Bmi-1 acts to inhibit the c-myc-dependent increase in
p19ARF as a mechanism to inhibit myc-associated apoptosis
(Jacobs et al., 1999b). Our studies show that expression of
Bmi-1 attenuates the UVB-dependent increase in pro-caspase
activation and PARP cleavage. Thus, the level of Bmi-1
present in the tissue may influence the tendency of the tissue
to undergo apoptosis – that is, high levels of Bmi-1 may make
the tissue resistant to light-induced apoptosis.
Thus, our studies show that Bmi-1 is expressed in cells of
both the basal and suprabasal epidermal layers, with more
intense staining in the suprabasal epidermis. It is particularly
interesting that Bmi-1 is expressed in the suprabasal cells, as
these cells have lost proliferative potential and are under-
going terminal differentiation. This suggests that Bmi-1 may
function in epidermis to maintain survival and prevent
premature terminal differentiation. It is also significant that
Bmi-1 is expressed in a high percentage of cells within tumors
and in involved psoriatic epidermis. In this context, the pro-
survival function of Bmi-1 may promote cell survival and
proliferation leading to tumor development. Its widespread
expression in proliferating and non-proliferating tissues in
epidermis suggests that Bmi-1 is not strictly a regulator of
stem cell survival in this tissue. It will be important in future
studies to address this hypothesis in vivo using animals that
express varied levels of Bmi-1 in the epidermis.
MATERIALS AND METHODS
Reagents and antibodies
OA was purchased from Calbiochem (San Diego, CA) and TPA was
purchased from Sigma (Milwaukee, WI). Cyclosporine A was
obtained from Ben Venue Laboratories (Bedford, OH). It is supplied
USP 250 mg per 5 ml (NDC 55390-122-10). One milliliter contains
50 mg cyclosporine, 650 mg Cremophor, and is 33.2% (v/v) absolute
alcohol. Rabbit polyclonal anti-caspase 3 (9665) was obtained from
Cell Signaling (Beverly, MA). Mouse monoclonal antibodies, includ-
ing anti-cyclin D1 (554180) and anti-PARP (no. 556494), were
obtained from BD Pharmingen (San Diego, CA). Mouse monoclonal
anti-Bmi-1 (ab14389) was purchased from Abcam Inc. (Cambridge,
MA) and mouse monoclonal anti-b-actin was obtained from Sigma
(A5441). Rabbit polyclonal antibodies against cdk2 (sc-163), cdk4
(sc-601), cyclin E (sc-481), a mouse monoclonal antibody specific for
p21cip1/waf1 (sc-6246), and a rabbit polyclonal antibody for p16Ink4a
(C-20) (sc-468) were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Secondary antibodies, including HRP-conjugated
sheep anti-mouse IgG (NA931) and HRP-conjugated donkey anti-
rabbit IgG (NA934), were purchased from Amersham Biosciences
(Arlington Heights, IL). Methyl-3H-thymidine was obtained from
Amersham Biosciences (TRK300, 25 Ci/mmol, 1 mCi/ml).
RT-PCR analysis
RT-PCR was performed using conventional methods. The primers for
Bmi-1 are 50-GGTCTAGACGGATCCCAAGCAGAAATGCATCG and
50-GGCTCGAGCATCTAGAAAGCTGTAATGGCATG. The primers
for amplification of human b-action were purchased from Strata-
gene, La Jolla, CA.
Bmi-1 adenovirus construction
The cDNA encoding human Bmi-1 (hBmi-1) (Alkema et al., 1993)
was amplified by RT-PCR using Xba1 site-encoding primers and total
RNA derived from primary cultures of human foreskin keratinocytes.
The upstream primer was 50-GGTCTAGACGGATCCCAAGCAGAAA
TGCATCG. This primer encodes XbaI and BamHI sites (underlined)
and the sequence in bold is identical to hBmi-1 (Alkema et al.,
1993). The hBmi-1 protein translation start codon is underlined. The
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downstream primer, 50-GGCTCGAGCATCTAGAAAGCTGTAATGG
CATG, is homologous to the non-coding sequence located down-
stream of the Bmi-1 coding sequence. The bold sequence is identical
to Bmi-1 sequence and the XbaI and XhoI sites are underlined. The
hBmi-1 cDNA product, approximately 1060 bp in length, was
cloned into the shuttle plasmid, pDE1sp1B, as an Xba1 fragment to
create pDE1sp1B-hBmi-1. A293 packaging cells were transfected
with pDE1sp1B-hBmi-1 and the pJM17 adenovirus backbone
plasmid to produce the hBmi-1-encoding adenovirus, tAd5-hBmi-
1. The empty adenovirus, tAd5-EV, and the Ad5-TA helper virus
were constructed as previously described (Dashti et al., 2001).
Cell culture
Normal human foreskin keratinocytes were cultured in keratinocyte
serum-free medium as previously described (Dashti et al., 2001).
A431, HaCaT, and SCC13 cells were cultured in DMEM:F12 (3:1)
containing 2 mM L-glutamine, 100 U/ml penicillin, 100 U/ml strepto-
mycin, 10% fetal calf serum, and non-essential amino acids.
Cell proliferation studies
Normal human keratinocytes were seeded into 9.5 cm2 dishes and
allowed to attach for 24 hours. The cells were then infected with
5 MOI of tAd5-EV (empty vector) or tAd5-hBmi-1 in the presence of
5 MOI of Ad5-TA and 2.5 mg/ml polybrene. Ad5-TA is a helper
adenovirus that encodes the tetracycline activator (TA). In the native
state, the TA protein activates transcription of the hBmi-1-encoding
transcription unit. Addition of tetracycline to the medium inactivates
TA and results in reduced levels of hBmi-1. At 24 hours post
infection, fresh medium was added, and after an additional 48 hours,
the cells were harvested using 0.025% trypsin/1 mM EDTA and
counted.
Immunoblot analysis
Subconfluent cultures of cells were infected with adenoviruses as
mentioned above for 24 hours. Fresh virus-free medium was added
and the cells were treated with 0 or 2 nM OA (24 or 48 hours) or UVB
(50 mJ/cm2) (FS20-T12 lamps with Kodacel filer, Ultraviolet Re-
sources International, Brookpark, OH). The cells were washed once
in phosphate-buffered saline (PBS), and lysates were prepared in
20 mM Tris-HCl (pH 7.5) containing 150 mM NaCl, 1 mM EGTA, 1 mM
EDTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM
b-glycerophosphate, 1 mM sodium vanadate, 1 mg of leupeptin, and
1 mM phenylmethylsulfonyl fluoride. Equal quantities of protein were
electrophoresed on 10% denaturing and reducing polyacrylamide
gels and transferred to nitrocellulose. The membranes were blocked
in 10 mM Tris-HCl (pH 7.2) containing 100 mM NaCl, 0.1% Tween
20, and 5% non-fat dry milk, and incubated with the appropriate
primary and secondary antibodies. Secondary antibody binding was
visualized using a chemiluminescent detection system.
Immunohistological detection of Bmi-1 in keratinocytes
For detection in cultured cells, human foreskin keratinocytes,
growing on coverslips, were fixed with 4% formaldehyde for
30 minutes, washed with PBS, and permeabilized for 30 minutes
using PBS containing 0.1% Triton X-100 and 1% BSA. The coverslips
were then incubated for 1 hour with mouse anti-Bmi-1 (1:100),
washed in PBS containing 0.1% Triton X-100 and 1% BSA, and
incubated for 30 minutes with Cy3-conjugated sheep anti-mouse IgG
(1:1,000) for 30 minutes. The cells were then washed with PBS
containing 0.1% Triton X-100 and 1% BSA and mounted in Mowiol
4-88-containing mounting agent. Bmi-1 distribution was monitored
by epifluorescence microscopy. For detection of Bmi-1 in human
skin biopsies, the tissue was harvested by punch biopsy, fixed in
formalin, and incubated with murine monoclonal anti-Bmi-1 (1:100)
followed by washing and incubation with HRP-conjugated goat anti-
mouse IgG (1:1,000). Antibody binding was visualized using the
Vectastain kit.
The human psoriasis skin-engrafted SCID mouse model
Keratome biopsy samples (0.05 cm thick) were collected from
involved psoriatic plaques from patients. For collection, three or
four individual graft segments (1.0–1.5 cm2) were divided out from
each patient biopsy, and a single small trim piece of each slice was
used for initial histological characterization. Within 24 hours after
collection, the tissue segments were engrafted onto 8-week-old
female CB-17 SCID mice (Taconic). In this method, the mice are
anesthetized and a 1.0 cm2 segment of skin was removed from the
lateral thorax. The 1.0–1.5 cm2 human skin graft is then secured at
this location using a band-aid strip, after applying sterile Vaseline-
impregnated gauze. Three to four mice receive tissue from the same
patient, and individual mice are normalized to different experi-
mental treatment groups. Approximately 2 weeks are allowed for
recovery before initiation of cyclosporine treatment. The mice are
treated twice weekly for 3 weeks with or without intra-graft injection
of 0.15 mg of cyclosporine A in a 50 ml volume (Dam et al., 1999). At
24 days after initiation of cyclosporine A treatment, the grafts are
collected for histological analysis and immunostaining with anti-
Bmi-1. These studies were approved by the institutional animal and
human use boards and all studies were performed according to the
Declaration of Helsinki Principles. The patients’ written, informed
consent was obtained for collection of all tissue samples.
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